Abstract
In this issue of Blood, Ramsay et al1 unravel a new mechanism of immune subversion induced by chronic lymphocytic leukemia (CLL) cells to perturb chemokine-oriented migration of both CD41 and CD81 T cells, and they propose an original cereblon-dependent effect of the immunomodulatory drug lenalidomide.
Cite
CITATION STYLE
APA
Ysebaert, L. (2013). T cells in CLL: Lost in migration. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2013-01-480384
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free